Displaying 31 - 34 of 34 articles
Nanoliposomes as Potential New Stroke Treatment
November 17, 2021
Stroke remains a leading cause of death and disability among veterans and the general public
A Novel Molecular First Responder Could Improve Patient Outcomes after Heart Attack or Stroke
June 16, 2021
Dr. Glembotski and his team of research scientists may revolutionize the treatment of cardiovascular diseases
Researchers Awarded $8 Million Grant to Study Depression and Cardiovascular Disease
November 30, 2020
Grant to better understand co-occurrence of major depression and heart disease
Christopher Glembotski, PhD, Appointed Director of the Center of Translational Cardiovascular Research
May 27, 2020
Dr. Glembotski is a renowned researcher in cardiovascular disease